Over the last 7 days, the Life Sciences industry has dropped 2.5%, driven by a pullback from XtalPi Holdings of 0.8%. In contrast, WuXi Biologics (Cayman) has gained 7.1%. In the past year, the industry has gained 91%. Looking forward, earnings are forecast to grow by 32% annually.
Has the Hong Kong Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 30 May 2025 | HK$208.9b | HK$36.2b | HK$2.6b | 28.6x | 80.3x | 5.8x |
Sun, 27 Apr 2025 | HK$188.9b | HK$35.4b | HK$2.5b | 25.9x | 74.6x | 5.3x |
Tue, 25 Mar 2025 | HK$215.3b | HK$32.6b | -HK$203,533,200.62 | 45.2x | -1058x | 6.6x |
Thu, 20 Feb 2025 | HK$195.8b | HK$35.8b | -HK$1,058,538,751.45 | 61.4x | -184.9x | 5.5x |
Sat, 18 Jan 2025 | HK$151.4b | HK$35.7b | -HK$1,061,954,767.87 | 54.6x | -142.6x | 4.2x |
Mon, 16 Dec 2024 | HK$154.0b | HK$35.8b | -HK$1,058,466,824.67 | 58.8x | -145.5x | 4.3x |
Wed, 13 Nov 2024 | HK$149.2b | HK$36.0b | -HK$1,057,244,947.38 | 41.8x | -141.1x | 4.1x |
Fri, 11 Oct 2024 | HK$168.2b | HK$35.9b | -HK$655,793,441.52 | 30.3x | -256.5x | 4.7x |
Sun, 08 Sep 2024 | HK$149.5b | HK$35.9b | -HK$658,597,307.62 | 23.4x | -227x | 4.2x |
Tue, 06 Aug 2024 | HK$94.8b | HK$33.8b | HK$3.1b | 18.8x | 30.2x | 2.8x |
Thu, 04 Jul 2024 | HK$88.3b | HK$33.4b | HK$3.1b | 18.7x | 28.7x | 2.6x |
Sat, 01 Jun 2024 | HK$90.1b | HK$33.5b | HK$3.1b | 27.5x | 29.1x | 2.7x |
Mon, 29 Apr 2024 | HK$108.0b | HK$33.6b | HK$3.1b | 30.6x | 34.9x | 3.2x |
Wed, 27 Mar 2024 | HK$111.8b | HK$33.2b | HK$3.7b | 49.4x | 30.5x | 3.4x |
Fri, 23 Feb 2024 | HK$134.7b | HK$32.3b | HK$3.0b | 54.1x | 45.3x | 4.2x |
Sun, 21 Jan 2024 | HK$197.8b | HK$32.5b | HK$3.0b | 85.7x | 65.4x | 6.1x |
Tue, 19 Dec 2023 | HK$211.8b | HK$32.4b | HK$3.0b | 88.2x | 70.6x | 6.5x |
Thu, 16 Nov 2023 | HK$273.0b | HK$30.3b | HK$2.7b | 48.2x | 101.1x | 9x |
Sat, 14 Oct 2023 | HK$262.3b | HK$30.1b | HK$2.7b | 46.9x | 98.3x | 8.7x |
Mon, 11 Sep 2023 | HK$223.8b | HK$30.1b | HK$2.7b | 40.1x | 84.3x | 7.4x |
Wed, 09 Aug 2023 | HK$234.0b | HK$28.4b | HK$2.7b | 22.6x | 86.3x | 8.3x |
Fri, 07 Jul 2023 | HK$205.0b | HK$28.3b | HK$2.7b | 20.4x | 76x | 7.2x |
Sun, 04 Jun 2023 | HK$235.5b | HK$28.9b | HK$2.8b | 20.9x | 84x | 8.2x |
Tue, 02 May 2023 | HK$249.3b | HK$29.5b | HK$2.9b | 24.5x | 85.3x | 8.5x |
Thu, 30 Mar 2023 | HK$252.7b | HK$28.9b | HK$2.4b | 22.4x | 103.2x | 8.8x |
Sat, 25 Feb 2023 | HK$282.2b | HK$26.2b | HK$2.0b | 24.6x | 139.7x | 10.8x |
Mon, 23 Jan 2023 | HK$371.2b | HK$26.6b | HK$2.1b | 27.8x | 174.2x | 14x |
Wed, 21 Dec 2022 | HK$265.7b | HK$25.9b | HK$2.0b | 23.6x | 133.7x | 10.3x |
Fri, 18 Nov 2022 | HK$275.7b | HK$25.7b | HK$1.9b | 26.6x | 143.8x | 10.7x |
Sun, 16 Oct 2022 | HK$258.7b | HK$25.5b | HK$1.9b | 21.4x | 139.4x | 10.1x |
Tue, 13 Sep 2022 | HK$343.4b | HK$26.3b | HK$2.0b | 25.7x | 168.7x | 13.1x |
Thu, 11 Aug 2022 | HK$356.6b | HK$22.3b | HK$2.0b | 11.7x | 174.5x | 16x |
Sat, 09 Jul 2022 | HK$418.6b | HK$22.4b | HK$2.1b | 14.6x | 201.2x | 18.7x |
Mon, 06 Jun 2022 | HK$299.3b | HK$22.5b | HK$2.1b | 13.1x | 142x | 13.3x |
142x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | 0.70% | |
Healthcare | 4.06% | |
Life Sciences | 7.05% | |
Clinical Research and Equipment | 7.05% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
2269 WuXi Biologics (Cayman) | HK$25.75 | 7.1% +HK$6.9b | 129.9% | PE28.6x | |
2268 WuXi XDC Cayman | HK$40.15 | 9.1% +HK$4.0b | 169.1% | PE41.4x | |
1548 Genscript Biotech | HK$12.88 | 9.5% +HK$2.4b | 27.8% | PS6x | |
1873 Viva Biotech Holdings | HK$1.87 | 12.7% +HK$442.9m | 192.2% | PE21.6x | |
1521 Frontage Holdings | HK$1.19 | 4.4% +HK$101.2m | 1.7% | PE388.3x |